PT-141

PT-141

  • Brand: Deus Medical
  • Product Code: PT-141
  • Availability: In Stock
  • $54.00



PRODUCT CLASSIFICATION Melanocortin Receptor Agonists
ACNE-FRIENDLY No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Deus Medical
LAB TEST INFORMATION See Document
STORAGE LOCATION EU Warehouse 2
ACTIVE INGREDIENT Bremelanotide

Introducing PT-141 (Bremelanotide), a revolutionary peptide designed to elevate libido effectively for both men and women. This synthetically produced compound is not only safe but also versatile, making it an ideal choice for men facing erectile dysfunction and women experiencing sexual difficulties.

Beyond its primary purpose, research has unveiled remarkable additional benefits of PT-141. It stimulates melanin production, leading to a beautiful tanning effect, and ongoing laboratory studies are expanding its potential applications even further.

What sets PT-141 apart from traditional medications like Viagra and Cialis is its unique mechanism. While those drugs primarily target blood flow, Bremelanotide directly enhances libido through its powerful active ingredients.

Users of PT-141 can expect a range of benefits, including:

  • Enhanced sexual potency
  • Increased sexual desire
  • Extended duration of intercourse
  • Heightened sensitivity

To achieve optimal results, it?s crucial to follow the dosage instructions for PT-141 closely.

DOSAGE AND ADMINISTRATION OF PT-141

For initial effects, a subcutaneous injection of 0.3 milligrams is recommended. This starting dose allows you to assess how your body responds to the active ingredients. If necessary, the dosage can be gradually increased, with the ideal range for a single administration being between 0.5 and 1.5 milligrams.

Users typically begin to notice the effects of Bremelanotide within a couple of hours, with peak responses occurring around 3-4 hours post-injection. The benefits can last anywhere from 8 to 10 hours, providing a lasting enhancement.

POTENTIAL SIDE EFFECTS AND CONTRAINDICATIONS

Clinical research confirms that Bremelanotide operates as intended, fulfilling its promise. However, some participants noted elevated blood pressure, prompting the discontinuation of further studies. User experiences also suggest that an overdose may lead to hypertension. While local reactions, such as redness at the injection site, can occur, they typically resolve quickly and are generally not serious.